AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Cyclacel Pharmaceuticals Inc. (CYCC) Surges to 113th in Trading Volume with $78.6 Million Turnover
Generated by AI AgentAinvest Volume Radar
Tuesday, Jul 15, 2025 7:22 pm ET1min read
On July 15, 2025, Cyclacel Pharmaceuticals Inc. (CYCC) experienced a significant surge in trading volume, with a turnover of $78.6 million, marking a 1617.50% increase from the previous day. This substantial rise placed
at the 113th position in terms of trading volume for the day. The stock price of CYCC soared by 272.51%, marking its third consecutive day of gains, with a cumulative increase of 232.35% over the past three days.Cyclacel Pharmaceuticals Inc. (CYCC) saw a notable decline in its share price during Tuesday's after-hours trading session, dropping to $10.27. This decrease was part of a broader trend of price volatility experienced by the company's stock.
During Tuesday's regular trading session, Cyclacel Pharmaceuticals Inc. (CYCC) shares surged by 400.0%, reaching $16.55. This significant increase was driven by positive market sentiment and investor interest in the company's recent developments.
In the pre-market session on Tuesday, Cyclacel Pharmaceuticals Inc. (CYCC) shares rose by 41.04%, reaching $4.67. This increase followed a previous day's decline, indicating a rebound in investor confidence.
Cyclacel Pharmaceuticals Inc. (CYCC) was one of the top performers on the NASDAQ Composite, with its shares rising by 270.39% to $12.26. This substantial gain highlighted the company's strong market position and investor optimism.
Ainvest Volume Radar
Hunt down the stocks with explosive trading volume.
Latest Articles
Kraft Heinz Slides 1.02% as Stock Ranks 486th in Daily Trading Volume Amid Institutional Splits Earnings Woes and Dividend Strain Weigh on Investor Confidence
Dec.05 2025
AVAV's 3.15% Slide Amid 21% Volume Drop, 475th Rank Signal Earnings Optimism Fizzles
Dec.05 2025
Align Technology Extends Three-Day Rally with 0.24 Gain Ranks 452nd in $250M Turnover as Dental Sector Outperforms Peers
Dec.05 2025
PPG's 0.36% Rise Outpaces 448th-Ranked Volume as Analysts Boost Aerospace Growth Outlook
Dec.05 2025
Akamai's FedRAMP Certification Drives 31.33% Volume Surge to 445th Rank, but Stock Dips 3.59% on Investor Caution
Dec.05 2025
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet